Arkolith/Insider Trading/EDSA/Form 4

Nijhawan Pardeep

Chief Executive Officer, Director, 10% OwnerEdesa Biotech, Inc. (EDSA) · full profile →Form 4 · filed Nov 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 2, 2022Grant(A)228K$1.13$258K2.4M
Nov 2, 2022Grant(A)228K$1.13$258K228K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 2, 2022Grant(A)114K——114K
Nov 2, 2022Grant(A)114K——114K
Nov 2, 2022Grant(A)114K——114K
Nov 2, 2022Grant(A)114K——114K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-22-014745) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML